What is iMerit?
Headquartered in San Jose, California, iMerit specializes in the critical domain of data labeling and enrichment. By providing the foundational data that powers algorithms in machine learning, computer vision, and natural language processing, the company serves as a vital link in the AI development pipeline. Its market position is defined by its ability to handle complex, high-stakes data requirements that automated systems cannot yet manage independently. By bridging the gap between raw data and actionable intelligence, iMerit enables enterprise clients to accelerate their AI deployment cycles and improve model accuracy in real-world applications.
How much funding has iMerit raised?
iMerit has raised a total of $23.5M across 2 funding rounds:
Series A
$3.5M
Series B
$20M
Series A (2015): $3.5M with participation from Omidyar Network, The Michael and Susan Dell Foundation, and Khosla Impact
Series B (2020): $20M led by CDC Group
Key Investors in iMerit
Omidyar Network
Omidyar Network is a philanthropic investment firm focused on shaping the digital revolution to promote shared power and prosperity, influencing critical areas of technology and society.
The Michael and Susan Dell Foundation
A charitable private foundation dedicated to accelerating human opportunity globally through investments in education, health innovation, and financial services.
Khosla Impact
A venture firm providing strategic advice and capital to entrepreneurs developing breakthrough technologies across sectors including AI, enterprise software, and robotics.
What's next for iMerit?
With the recent influx of capital, iMerit is well-positioned to deepen its technological moat and expand its global operational footprint. The company is expected to focus on scaling its proprietary platform, enhancing its workforce capabilities, and further integrating advanced automation into its annotation workflows. As the enterprise AI market matures, iMerit's strategic focus will likely shift toward addressing more specialized, high-complexity data challenges, such as those found in autonomous systems and advanced healthcare diagnostics. This trajectory suggests a continued emphasis on maintaining high-quality standards while scaling to meet the increasing volume of data required by global enterprise clients.
See full iMerit company page
